Improving PET imaging for better diagnosis of diseases
Leveraging ultra-fast Cherenkov emission in scintillator-based TOF-PET by exploiting photon wavelength classification
This study is working on making PET scans better by improving the way they capture light, which could help doctors see clearer images for diagnosing diseases like cancer and heart problems, while also making the process quicker and safer for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10823355 on NIH RePORTER |
What this research studies
This research focuses on enhancing the technology used in positron emission tomography (PET) imaging by separating different types of light emitted from scintillator crystals. By improving the time and energy resolution of PET detectors, the goal is to achieve clearer and more accurate images for diagnosing various diseases, including cancers and cardiovascular conditions. The approach involves utilizing both scintillation and Cherenkov light to optimize imaging performance, which could lead to reduced radiation exposure for patients and faster imaging times.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals undergoing PET scans for cancer, neurological disorders, or cardiovascular diseases.
Not a fit: Patients who do not require PET imaging or have conditions that are not diagnosed using this technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and safer imaging procedures for patients.
How similar studies have performed: Previous research has shown promising results in enhancing PET imaging through similar technological advancements, indicating potential for success in this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Seo, Youngho — University of California, San Francisco
- Study coordinator: Seo, Youngho
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.